Delivery Order SPE2DB22D2211-SPE2DB25FSCBK
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,404.04 to AmerisourceBergen Drug Corp, a subsidiary of the AmerisourceBergen Corporation, for the supply of Depo-Medrol 80 mg/mL vials. This delivery order contract was issued under an existing Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for DEPO-MEDROL 40 MG/ML VIALML, a pharmaceutical product, with a potential value of $1,155.82. The order has a completion date of January 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical supplies to DLA Troop Support Medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract is for the supply of DEPO-MEDROL 40 MG/ML vials, a specialty brand name medication, with a ceiling value of $4,234.53 and a period of performance through March 15, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA that serves as the primary vehicle for the company...
- AmerisourceBergen Drug Corp was awarded a firm fixed-price delivery order valued at $1,265.88 by the Defense Logistics Agency's Medical Supply Chain on August 22, 2025, for the supply of Solu-Medrol 500 mg vials. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 mg vials of Solu-Medrol, a corticosteroid medication commonly used for anti-inflammatory and immunosuppressant purposes in military and federal healthcare settings. This firm fixed-price delivery order, valued at $1,475.83, was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025. The contract was competitively awarded without set-aside designation and will be performed...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of SOLU-MEDROL 2,000 mg vials. This non-set-aside, firm fixed-price delivery order has a ceiling value of $1,002.48 and an ultimate completion date of July 14, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,273.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Methylprednisolone 400 mg/5 mL injections, with an ultimate completion date of September 10, 2025. This non-set-aside competitive award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract specifies performance at the company's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Solu-Medrol 40 mg vials valued at $5,223.67 with a firm fixed price structure. The contract, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,292.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Solu-Medrol 125mg in quantities of 25 units. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 16, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Solu-Medrol 1 gram vials, with a ceiling value of $3,636.56. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCBKDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,257.38 for DEPO-MEDROL 80 MG/ML vials on August 1, 2025, with completion expected by August 4, 2025. This firm fixed price, non-set-aside contract represents a pediatric or pharmaceutical supply order fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal medical supply contracts primarily with the Defense Logistics Agency and its Medical Supply Chain. The company's competitively awarded contracts demonstrate its capability to supply a wide range of pharmaceutical products and medical supplies to support defense and veteran healthcare systems. This specific delivery order for methylprednisolone acetate reflects the company's role as a critical vendor for federal military medical procurement, supplying medications across multiple therapeutic domains to support military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/1/25 |